These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36880170)

  • 21. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
    Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
    Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
    Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic Resistance Pattern Of Acinetobacter Baumannii Isolated From Bacteremia Patients In Pakistan.
    Jabeen F; Khan Z; Sohail M; Tahir A; Tipu I; Murtaza Saleem HG
    J Ayub Med Coll Abbottabad; 2022; 34(1):95-100. PubMed ID: 35466635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria.
    Mahdavi M; Findlay BL
    Bioorg Med Chem; 2024 Jan; 97():117541. PubMed ID: 38096681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital.
    Liu H; Hu D; Wang D; Wu H; Pan Y; Chen X; Qi L; Li L; Liang R
    J Antibiot (Tokyo); 2023 Jan; 76(1):20-26. PubMed ID: 36307731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
    Wareham DW; Bean DC
    Ann Clin Microbiol Antimicrob; 2006 Apr; 5():10. PubMed ID: 16630352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z; Jain R; Danziger LH
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
    De Oliveira DMP; Forde BM; Phan MD; Steiner B; Zhang B; Zuegg J; El-Deeb IM; Li G; Keller N; Brouwer S; Harbison-Price N; Cork AJ; Bauer MJ; Alquethamy SF; Beatson SA; Roberts JA; Paterson DL; McEwan AG; Blaskovich MAT; Schembri MA; McDevitt CA; von Itzstein M; Walker MJ
    mBio; 2022 Feb; 13(1):e0351721. PubMed ID: 35012353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant
    Menegucci TC; Fedrigo NH; Lodi FG; Albiero J; Nishiyama SAB; Mazucheli J; Carrara-Marroni FE; Voelkner NMF; Gong H; Sy SKB; Tognim MCB
    Microb Drug Resist; 2019 Nov; 25(9):1266-1274. PubMed ID: 31216222
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application progress of polymyxin in bloodstream infection of drug-resistant Acinetobacter baumannii].
    Zhang S; Sun L; Sun L; Yang Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1401-1404. PubMed ID: 34980319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-Bromo-2-naphthol from Silene armeria extract sensitizes Acinetobacter baumannii strains to polymyxin.
    Kang M; Kim W; Lee J; Jung HS; Jeon CO; Park W
    Sci Rep; 2022 May; 12(1):8546. PubMed ID: 35595766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Thamlikitkul V; Tiengrim S; Seenama C
    J Med Assoc Thai; 2014 Dec; 97(12):1254-8. PubMed ID: 25764631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B
    Akrong G; Chauzy A; Aranzana-Climent V; Lacroix M; Deroche L; Prouvensier L; Buyck JM; Couet W; Marchand S
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0178921. PubMed ID: 34780268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii.
    Lim TP; Ong RT; Hon PY; Hawkey J; Holt KE; Koh TH; Leong ML; Teo JQ; Tan TY; Ng MM; Hsu LY
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7899-902. PubMed ID: 26438500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.